Modular Medical (NASDAQ:MODD – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.01), Zacks reports.
Modular Medical Trading Down 4.3 %
NASDAQ MODD opened at $1.10 on Friday. Modular Medical has a 52 week low of $1.10 and a 52 week high of $2.65. The company has a 50 day moving average price of $1.34 and a 200 day moving average price of $1.77.
Insider Buying and Selling at Modular Medical
In related news, CEO Manchester Management Co Llc purchased 166,666 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were acquired at an average price of $1.50 per share, for a total transaction of $249,999.00. Following the purchase, the chief executive officer now owns 3,284,743 shares of the company’s stock, valued at $4,927,114.50. This trade represents a 5.35 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last quarter, insiders have purchased 287,666 shares of company stock worth $454,279. 20.46% of the stock is owned by corporate insiders.
Modular Medical Company Profile
Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
Read More
- Five stocks we like better than Modular Medical
- Investing In Automotive Stocks
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
- Are Penny Stocks a Good Fit for Your Portfolio?
- MarketBeat Week in Review – 02/10 – 02/14
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.